AI Verdict
INVH has stronger fundamentals based on our AI analysis.
IOBT vs INVH Fundamental Comparison
| Metric | IOBT | INVH |
|---|---|---|
| Revenue | N/A | $2.7B |
| Net Income | $-57.0M | $587.9M |
| Net Margin | N/A | 21.5% |
| ROE | -6,258.6% | 6.2% |
| ROA | -142.7% | 3.1% |
| Current Ratio | 2.01x | N/A |
| Debt/Equity | 18.29x | 0.88x |
| EPS | $-0.86 | $0.96 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOBT vs INVH: Frequently Asked Questions
Is IOBT or INVH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), INVH has stronger fundamentals. IOBT is rated STRONG SELL (95% confidence) while INVH is rated BUY (72% confidence). This is not investment advice.
How does IOBT compare to INVH fundamentally?
IO Biotech, Inc. has ROE of -6,258.6% vs Invitation Homes Inc.'s 6.2%. Net margins are N/A vs 21.5% respectively.
Which stock pays higher dividends, IOBT or INVH?
IOBT has a dividend yield of N/A or no dividend while INVH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOBT or INVH for long term?
For long-term investing, consider that IOBT has STRONG SELL rating with 95% confidence, while INVH has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOBT vs INVH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOBT vs INVH, the AI consensus favors INVH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.